Semler Scientific, Inc. (SMLR)

NASDAQ: SMLR · IEX Real-Time Price · USD
47.34
-0.38 (-0.80%)
Feb 23, 2024, 4:00 PM EST - Market closed
-0.80%
Market Cap 325.38M
Revenue (ttm) 66.92M
Net Income (ttm) 19.58M
Shares Out 6.87M
EPS (ttm) 2.50
PE Ratio 18.94
Forward PE 13.53
Dividend n/a
Ex-Dividend Date n/a
Volume 32,769
Open 47.72
Previous Close 47.72
Day's Range 46.64 - 47.98
52-Week Range 19.12 - 53.38
Beta 0.94
Analysts n/a
Price Target n/a
Earnings Date Mar 5, 2024

About SMLR

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, ... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Feb 21, 2014
Employees 127
Stock Exchange NASDAQ
Ticker Symbol SMLR
Full Company Profile

Financial Performance

In 2022, SMLR's revenue was $56.69 million, an increase of 6.90% compared to the previous year's $53.03 million. Earnings were $14.33 million, a decrease of -16.82%.

Financial Statements

News

Semler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024

SANTA CLARA, Calif. , Feb. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev...

4 days ago - PRNewsWire

Semler Scientific Reports Third Quarter and Year-to-Date 2023 Financial Results

2023 Q3 highlights: Revenue of $16.3 million, an increase of 16% compared to the corresponding period of 2022 Net income of $5.5 million, an increase of 50% compared to the corresponding period of 202...

3 months ago - PRNewsWire

Semler Scientific to Report Third Quarter and First Nine Months of 2023 Financial Results and Host Conference Call on November 9, 2023

SANTA CLARA, Calif. , Oct. 26, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev...

4 months ago - PRNewsWire

Semler Scientific to Present at Upcoming Investor Conference

SANTA CLARA, Calif. , Aug. 31, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev...

6 months ago - PRNewsWire

Semler Scientific Reports Second Quarter and First Half of 2023 Financial Results

2023 Q2 highlights: Revenue was $18.6 million, an increase of 25% compared to the corresponding period of 2022 Net income was $5.9 million, an increase of 44% compared to the corresponding period of 2...

7 months ago - PRNewsWire

Semler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023

SANTA CLARA, Calif. , July 28, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev...

7 months ago - PRNewsWire

Semler Scientific Announces Appointment of Chief Financial Officer, Record Quarterly Revenues and Strategic Streamlining

SANTA CLARA, Calif. , July 11, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev...

8 months ago - PRNewsWire

Semler Scientific to Join the Russell 2000® and 3000® Indexes

SANTA CLARA, Calif. , June 23, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev...

8 months ago - PRNewsWire

Semler Scientific Reports First Quarter 2023 Financial Results

2023 Q1 highlights: Revenue was $18.2 million, an increase of 30% compared to the corresponding period of 2022 Net income was $5.0 million, an increase of 48% compared to the corresponding period of 2...

10 months ago - PRNewsWire

Semler to Report First Quarter 2023 Financial Results and Host Conference Call on May 10, 2023

SANTA CLARA, Calif. , May 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcar...

10 months ago - PRNewsWire

Semler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEO

SANTA CLARA, Calif. , April 28, 2023 /PRNewswire/ -- The board of directors of Semler Scientific, Inc. (Nasdaq: SMLR), is pleased to announce that it has appointed Doug Murphy-Chutorian, M.D.

10 months ago - PRNewsWire

Semler Scientific Announces Appointment of Eric Semler and William Chang as Directors

Eric Semler Appointed as Chairman SANTA CLARA, Calif. , April 19, 2023 /PRNewswire/ -- - Semler Scientific, Inc. (Nasdaq: SMLR) today announced that Eric Semler and William H.C.

11 months ago - PRNewsWire

Semler Scientific to Participate in the 22nd Annual Needham Virtual Healthcare Conference

SANTA CLARA, Calif. , April 5, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...

11 months ago - PRNewsWire

Semler Scientific Comments on CMS Risk Adjustment Changes in the 2024 Medicare Advantage and Part D Final Rate Announcement

SANTA CLARA, Calif. , April 3, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...

11 months ago - PRNewsWire

Semler Scientific Reports Fourth Quarter and Full Year 2022 Financial Results

2022 Q4 and Full Year highlights compared to the corresponding period of 2021: Fourth quarter revenue was $13.8 million, an increase of 20% Fourth quarter net income was $3.2 million, an increase of 1...

1 year ago - PRNewsWire

Semler Scientific Names Wayne T. Pan, M.D., Ph.D.

SANTA CLARA, Calif. , March 21, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of health...

1 year ago - PRNewsWire

Semler Announces Clinical Study Published Using QuantaFlo® as an Aid for Diagnosis of Heart Dysfunction in the Primary Care Setting

SANTA CLARA, Calif. , March 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...

1 year ago - PRNewsWire

Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible

SANTA CLARA, Calif. , Dec. 14, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...

1 year ago - PRNewsWire

Semler Announces Investment in Monarch Medical Technologies

SANTA CLARA, Calif. , Dec. 12, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...

1 year ago - PRNewsWire

Semler Reports Third Quarter and Year-to-Date 2022 Financial Results

2022 Q3 quarterly HIGHLIGHTS compared to the corresponding period of 2021: Revenue was $14.0 million, same as the prior year period Net income was $3.7 million, or $0.55 per basic share and $0.46 per ...

1 year ago - PRNewsWire

Semler to Report Third Quarter and First Nine Months of 2022 Financial Results and Host Conference Call on November 1, 2022

SANTA CLARA, Calif. , Oct. 19, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...

1 year ago - PRNewsWire

Semler Scientific to Present at Upcoming Investor Conferences

SANTA CLARA, Calif. , Aug. 31, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...

1 year ago - PRNewsWire

Semler Reports Second Quarter and First Half of 2022 Financial Results

2022 Q2 quarterly HIGHLIGHTS compared to the corresponding period of 2021: Revenues were $14.8 million, an increase of 4%, compared to $14.3 million Net income was $4.1 million, or $0.60 per basic sha...

1 year ago - PRNewsWire

Semler to Report Second Quarter and First Half 2022 Financial Results and Host Conference Call on August 2, 2022

SANTA CLARA, Calif. , July 21, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...

1 year ago - PRNewsWire

Semler Reports First Quarter 2022 Financial Results

2022 Q1 HIGHLIGHTS compared to the corresponding period of 2021: Revenues were $14.0 million, an increase of $0.8 million, or 6%, compared to $13.2 million Net income was $3.4 million, or $0.50 per ba...

1 year ago - PRNewsWire